Molecular markers

• P 12-01 • Inter-observer agreement on interpretation of dual stained p16/Ki-67 samples in a HPV positive primary screening population > C. Christine White • P 12-02 • IS RNA EXTRACTION METHOD CRUCIAL FOR HUMAN PAPILLOMAVIRUS E6/E7 ONCOGENES DETECTION? > M. Miren Basaras • P 12-03 • DETECTION OF HIGH RISK HPV TYPES AND RISK PREDICTION OF CERVICAL CANCER > G. Guoliang Fu • P 12-04 • EXPRESSION AND CLINICAL SIGNIFICANCE OF ANGIOPOIETIN-1, ANGIOPOIETIN-2, TIE2 RECEPTOR AND HPV STATUS IN PATIENTS WITH PENILE CARCINOMAS > V. Vera Saddi • P 12-05 • CERVICAL CANCER CELL LINES MEMBRANE PROTEOMICS OFFER NEW INSIGHTS IN THE DISEASE MECHANISMS > K. Kalliopi Pappa • P 12-06 • COULD METHYLATION ASSAYS FOR EARLY DETECTION OF CIN2+ LEAD TO OVERTREATMENT? – CASE REPORT > F. Fernanda Costa • P 12-07 • XRCC1 rs1799782 and ERCC2 rs13181 POLYMORPHISMS AS POTENTIAL PROGNOSTIC AND PREDICTIVE FACTORS IN CERVICAL CANCER PATIENTS > A. Augusto Nogueira • P 12-08 • P16 IN THE HISTOLOGICAL DIAGNOSIS OF THE INTRAEPITHELIAL NEOPLASIAS OF THE CERVIX: EVALUATION AND PROPOSALS FOR USE. > A. Ana Forteza • P 12-09 • Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology > E. Eliana Peeters • P 12-10 • Detection of potential biomarkers in the high grade anal intraepithelial neoplasia from HIV/HPV co-infected MSM > A. Alcina F Nicol